Gooch, K. E., Smith, T. R., Salguero, F. J., Fotheringham, S. A., Watson, R. J., Dennis, M. J., . . . Carroll, M. W. (2021). One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model. Vaccine.

Gooch, Karen E., et al. "One or Two Dose Regimen of the SARS-CoV-2 Synthetic DNA Vaccine INO-4800 Protects against Respiratory Tract Disease Burden in Nonhuman Primate Challenge Model." Vaccine 2021.

Gooch, Karen E., et al. "One or Two Dose Regimen of the SARS-CoV-2 Synthetic DNA Vaccine INO-4800 Protects against Respiratory Tract Disease Burden in Nonhuman Primate Challenge Model." Vaccine 2021.